Two clinical psychologists from the United States, Stephen Gold and Michael Quiñones,...
At the EXPIO Center, we strive to better understand the nature of war-related trauma and its impact on mental health. Together with the NGO "Foundation for the Development of Medicine and Psychosocial Support" we are initiating a clinical trial to develop an effective treatment for post-traumatic stress disorder (PTSD) and anxiety and depression in patients who do not respond to traditional therapies.
"A monocentric randomized, double-blind, placebo-controlled clinical trial of ketamine-assisted integrative psychotherapy in patients with treatment-resistant PTSD"
Patients(except for military personnel and veterans - research with them is prohibited during the war) of any gender, aged 18-55 years, who have experienced military trauma and are diagnosed with treatment-resistant PTSD are invited to participate.
Participation in the study is free for anyone who meets the selection criteria.
The duration of the therapeutic stage is 4-5 weeks.
Participants will be randomly divided into two groups:
The experimental group will receive ketamine 0.5 mg/kg intravenously twice a week plus integrative psychotherapy sessions.
The control group received midazolam twice a week plus identical psychotherapy.
Group rotation: after the first stage, participants in the control group who did not show significant improvement will be able to undergo ketamine therapy.
level of PTSD, depression, and anxiety symptoms;
quality of life;
general functioning.
Ketamine is a well-known drug with a 40-year history of use as an anesthetic.
In small doses, it has a strong psychotherapeutic effect.
In 2019, the FDA approved it for the treatment of resistant depression.
Studies have shown the effectiveness of ketamine in the treatment of PTSD - even a single injection can have a quick and lasting effect.
In combination with psychotherapy, its effectiveness increases significantly.
The study was approved by the Ethics Committee of the Ukrainian Institute for Public Health Policy.
All information will be kept confidential.
The data can only be used for scientific purposes in an anonymized form.
Providing contact and basic personal data.
Signing an informed consent.
Filling out psychological questionnaires (≈ 45 minutes).
Medical examination and tests (at the beginning and at the end).
Visits to the center 3 times a week for 2-3 hours (day hospital).
Permission to contact you in 3-6-12 months to assess the long-term effects.
Permission to share data anonymously with other research organizations.
📩 If you meet the criteria and are ready to participate, fill out the form below.
📞 If you have any questions, please contact us by phone: 07373 080 88
We invite sponsors, philanthropists and activists to support our research into the latest methods of treating trauma! Make a donation HERE.
Assistance in restoring psychological balance and resources.
Working with anxiety, physical symptoms and fear of losing control
Modern methods of overcoming fears that interfere with life.
Therapy for people with post-traumatic experiences.
A health disorder that occurs due to somatization, that is, the "embodiment" of negative emotions in the body.
Psycho-oncology is psychotherapeutic care for patients with cancer.
Two clinical psychologists from the United States, Stephen Gold and Michael Quiñones,...
We are always open to communication. Contact us and we will answer all your questions and help you find the right solution.
Expio in Kyiv
Expio in Lviv
License of the Ministry of Health of Ukraine: Order No. 1443 dated 11.08.2023. License of the State Service of Ukraine on Medicines and Drugs Control: Order No. 1065 dated 11.07.2024
(from 2018 to 2024, the order of the SLC dated 25.10.2018 for V.L. Matrenytskyi, sole proprietor).
© Expio 2025 All rights reserved. / Designed by Bereshkaweb